Crowdonomics
All companies
CB Therapeutics, Inc. logo

CB Therapeutics, Inc.

Operating

Healthcare · Founded 2015

Visit website

Advanced synthetic biology for planet and human health

Valuation cap ⓘ
$45.0M
As of Apr 2023 · from CB Therapeutics , Inc. Crowd SAFE 1 · a SAFE/note conversion ceiling, not a priced valuation
Total raised
$0
Across 1 round since 2023

Financials

FY2020–FY2021 · from SEC filings · hover any figure for its source
$0
−$2.3M
2020
$2.0M
−$1.8M
2021
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2020
FY2021
Income statement
Revenue
$0
$2,014,066
Cost of goods sold
$0
$0
Gross margin
—
100%
Net income
-$2,278,343
-$1,772,158
Taxes paid
$1,600
$3,017
Balance sheet
Cash
$13,453
$1,810,709
Accounts receivable
$0
$14,066
Total assets
$910,015
$3,722,376
Short-term debt
$677,795
$287,110
Long-term debt
$730,988
$188,555
Total liabilities
$1,408,783
$475,665
Other
Headcount
—
18

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Valuation over rounds

Post-money = pre-money + amount raised · caps marked
$45.0M
Valuation cap
CB Therapeutics , Inc. Crowd SAFE 1

A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.

Fundraising history

CB Therapeutics , Inc. Crowd SAFE 1WithdrawnReg CF · SAFE · via Republic
Raised $10.8K / $1.2MInvestors 32Valuation cap $45M

Team

3 people
Sher Ali-Butt
President and Chief Executive Officer
Jacob Vogan
Director
Jeffrey Miller
Director

Names and titles as disclosed on SEC Form C. Bios and photos come from the platform campaign page and may be out of date.

Reg CF annual-report compliance

Not obligated

never closed a Reg CF raise

32 investors
holder-count proxy

Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.

SEC filings

  • Form C-WApr 11, 20230001949369-23-000002
    EDGAR
  • Form CFeb 27, 20230001949369-23-000001
    EDGAR
Source: ManualCIK 0001949369

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.